New startup can ZAP bacterial biofilms off metallic joints post-up.
Often there is a silent killer lurking beneath the skin, turning orthopedic implants into ticking time bombs of infection—resistant to […]
Often there is a silent killer lurking beneath the skin, turning orthopedic implants into ticking time bombs of infection—resistant to […]
The Medline IPO is a strong signal. Maybe we will see more Ortho PE IPOs in 2026. I would watch
In a poignant LinkedIn post that has resonated across the orthopedic community, Robert Clayton, President of the British Orthopaedic Foot
Why Read Over time in orthopedics, we have all seen the focus shift away from clinical innovation and patient outcomes
NOTE: This article will tell you who Reinhold is based on his early work. It was written in 2011 and
Our industry has created fortunes for those who navigate it with precision. From trailblazing entrepreneurs like Dane Miller or Maurice
The appetite for risk in orthopedic medical device companies evolves dramatically with their size—reflecting changes in resources, priorities, and stakeholder
Over the years I have watched many orthopedic companies rename themselves, or rebrand themselves or pivot. Most of the time
I am watching the soft tissue repair revolution heating up fast. Rotator cuff tears alone affect millions, with re-tear rates
If you are not an OrthoStreams subscriber, you can read the full details here – https://lnkd.in/g7dS_B4K Tiger Buford and Andrea Davis are brokering
My perspective is completely different from the BoneZone piece this week, Robots Are Setting the New Standard of Surgical Care,
Many startups are struggling to raise capital and rather than drive off the cliff, there is an option available –
I know Product Development because I led PD for 35 years. People in organized ortho companies call me asking: “Why
Why Read If you’re leading or working in an orthopedics or medtech engineering and innovation team, stop scrolling and read
I am watching the joint preservation movement growing rapidly. Patients do not trust their orthopedists 100% any longer. Especially when
As we prepare to enter 2026, Surgeons are still being blasted with features, features, features at medical shows and over
Why This Matters As someone who’s been covering ortho innovations for years, I see RepSource as a breath of fresh
Today, we’re talking robots. Not the flashy surgical arms stealing the spotlight in the OR, but the unsung heroes that
I am thrilled to share the inaugural edition of The Tiger Dashboard with everyone—for this month only. These are my
In our industry, many ortho surgeons often stick with the products they know, even when newer options hit the market.
If you’ve been in the ortho industry for any time, you know the big dogs like Stryker, Zimmer Biomet, and
This new startup is pioneering Therapeutic Hardware with 3D-printed porous pedicle screws that mimic bone’s trabecular structure to enhance integration,
Heard on the street. This is going to be a wild few months with a ton of disruption in people.
Too many startup CEOs call me with excitement about their company, when its not a company yet. It’s a science
Shame on Aesculap: A $38.5M Settlement Exposes Device Failures, Kickbacks, and Why Foreign Ortho Giants Hesitate on the U.S. Market
What happened at NASS this year? Spoiler: It was less “spine-tingling breakthroughs” and more “spine-tingling hangovers from ghost tours.” Let’s
Meduloc is revolutionizing small-bone trauma care with its FDA-cleared, minimally invasive nitinol intramedullary implants that deliver precise reduction, rotational stability,
Hey folks, Tiger Buford here with a quick dive into the spine market as NASS 2025 kicks off in Denver.
There is a seismic shift underway in spine. Traditional rigid fusions, once the standard for treating degenerative disc disease, are
Orthopedists may have more employment freedom as Non-Compete Agreements continue to evolve in the US. While the FTC’s proposed nationwide
In orthopedic startups—where innovation in joint replacements, regenerative therapies, or AI-driven surgical planning can make or break your venture—it’s easy
In total hip surgery, few topics spark as much debate as hip stability in total hip replacements (THR). Recently, I
Orthopedics has shifted—you feel it in your bones. Don’t hate me. I talk with alot of people, and just share
Why Read? Ortho sales is hyper-competitive. Reps must juggle high-stakes interactions in operating rooms and hospitals while grappling with scattered
It’s earnings season and we had two crazy stock moves after Q3 2025 earnings calls last week. Globus accelerated and
Which of these resonates with you the most? Vote by commenting your favorite number below—I’d love to hear why it
In the world of orthopedics, few stories capture the highs and lows like Exactech’s— from groundbreaking innovation to crippling recalls
Tiger’s Take: Acumed has made a strategic purchase of certain assets developed by TECHFIT Digital Surgery, particularly the DISRP online
The current funding environment is notoriously challenging, particularly in the Ortho space. On a discussion with the BoneChat community, finance
The Big Orthos continue to grow with their access advantages, new products from M&A, and organized sales force. The pattern
“The hardest startup challenge: Building a sales force that converts.” The single hardest challenge for any orthopedic startup isn’t product
I received a call from an orthopedic surgeon: “How do I break into venture capital as a physician?” The answer
In orthopedics, innovation drives competition and talent is the ultimate differentiator, and companies sometimes need to make moves in the
I’m about to offend a few of my orthopedic colleagues, but I have to be honest—this is a real challenge
Why read? This is a comprehensive article of the role of genome mapping in orthopedic medicine, posing the question why
Why read this? Real-time data from inside the body will become a tool that all patients and healthcare providers use
My clinical friends in ortho are going to hate this topic. We are going to talk about an uncomfortable aspect
Venture money has been tight for over three years and counting, so a few ortho businesses are tapping into the
Orthopedics has long grappled with an accuracy conundrum—not in the finesse of individual techniques, but in the elusive quest to
Why Read? You and I both know that printing tissue from our own cells is the future of ortho. It’s